Navigation Links
Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research

New York, NY (PRWEB) May 22, 2013

Patients with type 1 diabetes (T1D) who are treated with insulin pump therapy have better glycemic control as measured by significantly lower HbA1C levels than patients with T1D who treat their condition with insulin injections, according to new findings from the National Health and Wellness Survey (NHWS), conducted by Kantar Health. The research was presented at the 18th Annual International Meeting for ISPOR (International Society for Pharmacoeconomics and Outcomes Research) in New Orleans.

“Patients with type 1 diabetes who have better access to healthcare are more likely to use insulin pump therapy, but even after adjusting for these differences in multivariable modeling we found that insulin pump therapy is a significant predictor of patients’ clinical outcomes,” said Shaloo Gupta, MS, senior research analyst with Kantar Health. “In particular, patients with type 1 diabetes using insulin pump therapy are more likely to control their diabetes than those who are taking insulin injections.”

Patients with T1D who use insulin pump therapy reported significantly lower levels of HbA1C than patients who take multiple daily insulin injections. Nearly 40 percent of those using insulin pump therapy reported HbA1C levels of less than 7 percent, which is considered to be controlled, versus 24 percent of patients using insulin injections.

“Having consistently high HbA1C levels can increase the risk of developing microvascular and macrovascular complications, such as cardiovascular disease, kidney failure, blindness and neuropathy, among those with diabetes,” Gupta said. “Our research suggests that insulin pump therapy is associated with lower blood sugar levels and therefore may lower the risks of these serious complications.”

Visit Kantar Health’s website to download the full poster, “The Effect of Insulin Pump Therapy on HbA1C among Those with Type 1 Diabetes.”

About the National Health and Wellness Survey (NHWS)
The study’s results were drawn from the 2009, 2010, 2011 and 2012 U.S. NHWS, a nationally representative, self-administered survey conducted annually. Topics covered include the health status, attitudes, behaviors and outcomes among adults 18 or older.

Kantar Health conducts the NHWS in the U.S., Europe, Asia and Latin America. The survey is the largest self-reported dataset in the healthcare industry.

About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech, and medical device and diagnostic companies. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from pre-clinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tiny RNA molecule may have role in polycystic ovary syndrome, insulin resistance
2. Case Western Reserve receives Helmsley Trust grant to develop new glucose-sensitive insulin
3. Taking insulin for type 2 diabetes could expose patients to greater risk of health complications
4. Binge drinking increases risk of Type 2 diabetes by causing insulin resistance
5. Stop diabetes with insulin tablets
6. JDRF announces winners of first phase of Agnes Varis Glucose-Responsive Insulin Challenge
7. Single gene cause of insulin sensitivity may offer insight for treating diabetes
8. Scientists ID Gene for Insulin Sensitivity
9. New marker for identifying precursors to insulin-producing cells in pancreas
10. Link between brain insulin resistance, neuronal stress in worsening Alzheimers disease
11. No Cancer Risk From Long-Acting Insulin: Studies
Post Your Comments:
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... conversation at the recent 2015 American Dental Association meeting in Washington D.C. revolved around ... help protect a patient’s overall health. The talk stressed the link between periodontal disease ...
(Date:11/27/2015)... ... 27, 2015 , ... The rapid speed at which Americans ... more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming ... The forgotten part of this equation: 80 percent of medical care occurs in ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I ... an inventor from Hillside, N.J. "Many people catch diseases simply from sitting on ... will always be protected from germs." , He developed the patent-pending QUDRATECS to ...
(Date:11/27/2015)... ... November 27, 2015 , ... ProSidebar: Fashion is ... Pro X. With ProSidebar: Fasion, video editors can easily add an informative sidebar ... minimalist title opener. Utilize presets featuring self-animating drop zones, lines, bars, and text ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec ... Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users ... Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... -- Research and Markets ( ) has ... Horizons and Growth Strategies in the Italian Therapeutic ... Forecasts, Competitive Intelligence, Emerging Opportunities" report to ... --> This new 247-page report provides ... monitoring market, including emerging tests, technologies, instrumentation, sales ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Marker Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
(Date:11/25/2015)... SYDNEY , Nov. 26, 2015  The total global ... nearly 7% over 2015-2016. Latin America ... Asia , (excluding Japan ), is ... continues to face increased healthcare expenditure. In 2013-2014, ... expenditure declined from 43.5% in 2008-2009 to 41.2% in 2013-2014. ...
Breaking Medicine Technology: